Michael Binks

ScholarGPS® ID: 36314881783910

Affiliation

Pfizer Inc., New York, United States

Affiliation History

Field

Medicine

Discipline

Immunology

Top Specialties

Duchenne Muscular Dystrophy | Muscular Dystrophy

Metrics Summary

Publication Count

Predicted Citations

730

Predicted h-index

Ranking

Publications and Citation History

Publications based on Top Specialties

Types of Publication

Publications
Books
Patents
NIH/NSF

Add Delete
Safety, Tolerability, and Pharmacokinetics of Intravenous Doses of PF‐07304814, a Phosphate Prodrug Protease Inhibitor for the Treatment of SARS‐CoV‐2, in Healthy Adult Participants (journal article) Zhu, Tong \| Pawlak, Sylvester \| Toussi, Sima S. \| Hackman, Frances \| Thompson, Kimberly \| Song, Wei \| Salageanu, Joanne \| Winter, Erica \| Shi, Haihong \| Winton, Jennifer \| Binks, Michael Clinical Pharmacology in Drug Development, volume 11, issue 12, pages 1382-1393 (2022). 10.1002/cpdd.1174 Cited by (6) \| Cite \| Source
Dystrophin and mini-dystrophin quantification by mass spectrometry in skeletal muscle for gene therapy development in Duchenne muscular dystrophy (journal article) Farrokhi, Vahid \| Walsh, Jason \| Palandra, Joe \| Brodfuehrer, Joanne \| Caiazzo, Teresa \| Owens, Jane \| Binks, Michael \| Neelakantan, Srividya \| Yong, Florence \| Dua, Pinky \| ... \| Neubert, Hendrik Gene Therapy, volume 29, issue 10-11, pages 608-615 (2022). 10.1038/s41434-021-00300-7 Cited by (11) \| Cite \| Source
Pharmacokinetics of Oral Nirmatrelvir/Ritonavir, a Protease Inhibitor for Treatment of COVID ‐19, in Subjects With Renal Impairment (journal article) Toussi, Sima S. \| Neutel, Joel Michael \| Navarro, Jesus \| Preston, Richard Alfred \| Shi, Haihong \| Kavetska, Olga \| LaBadie, Robert R. \| Binks, Michael \| Chan, Phylinda L.S. \| Demers, Neil \| ... \| Damle, Bharat Clinical Pharmacology & Therapeutics, volume 112, issue 4, pages 892-900 (2022). 10.1002/cpt.2688 Cited by (41) \| Cite \| Source
Innovative Randomized Phase I Study and Dosing Regimen Selection to Accelerate and Inform Pivotal COVID‐19 Trial of Nirmatrelvir (journal article) Singh, Ravi Shankar P. \| Toussi, Sima S. \| Hackman, Frances \| Chan, Phylinda L. \| Rao, Rohit \| Allen, Richard \| Van Eyck, Lien \| Pawlak, Sylvester \| Kadar, Eugene P. \| Clark, Frances \| ... \| Bergman, Arthur Clinical Pharmacology & Therapeutics, volume 112, issue 1, pages 101-111 (2022). 10.1002/cpt.2603 Cited by (85) \| Cite \| Source
DMD - BIOMARKERS (journal article) Farrokhi, V. \| Walsh, J. \| Palandra, J. \| Brodfuehrer, J. \| Caiazzo, T. \| Owens, J. \| Binks, M. \| Neelakantan, S. \| Yong, F. \| Neubert, H. Neuromuscular Disorders, volume 31 (2021). 10.1016/j.nmd.2021.07.185 Cite \| Source
Safety and Disease Monitoring Biomarkers in Duchenne Muscular Dystrophy: Results From A Phase Ii Trial (journal article) Wagner, Kathryn R \| Guglieri, Michaela \| Ramaiah, Shashi K \| Charnas, Lawrence \| Marraffino, Shannon \| Binks, Michael \| Vaidya, Vishal S \| Palmer, Jeffrey \| Goldstein, Richard \| Muntoni, Francesco Biomarkers in Medicine, volume 15, issue 15, pages 1389-1396 (2021). 10.2217/bmm-2021-0222 Cited by (8) \| Cite \| Source
Quantitative Muscle Mri Biomarkers in Duchenne Muscular Dystrophy: Cross-Sectional Correlations with Age and Functional Tests (journal article) Sherlock, Sarah P \| Zhang, Yao \| Binks, Michael \| Marraffino, Shannon Biomarkers in Medicine, volume 15, issue 10, pages 761-773 (2021). 10.2217/bmm-2020-0801 Cited by (14) \| Cite \| Source
Randomized phase 2 trial and open-label extension of domagrozumab in Duchenne muscular dystrophy (journal article) Wagner, Kathryn R. \| Abdel-Hamid, Hoda Z. \| Mah, Jean K. \| Campbell, Craig \| Guglieri, Michela \| Muntoni, Francesco \| Takeshima, Yasuhiro \| McDonald, Craig M. \| Kostera-Pruszczyk, Anna \| Karachunski, Peter \| ... \| Wong, Brenda L. Neuromuscular Disorders, volume 30, issue 6, pages 492-502 (2020). 10.1016/j.nmd.2020.05.002 Cited by (41) \| Cite \| Source
P.341A phase 2 randomized placebo-control trial of domagrozumab in boys with Duchenne muscular dystrophy (DMD) (journal article) Marraffino, S. \| Binks, M. \| Palmer, J. \| Sherlock, S. \| Purohit, V. \| Charnas, L. Neuromuscular Disorders, volume 29 (2019). 10.1016/j.nmd.2019.06.455 Cited by (1) \| Cite \| Source
Report of a TREAT-NMD/World Duchenne Organisation Meeting on Dystrophin Quantification Methodology (journal article) Aartsma-Rus, Annemieke \| Morgan, Jennifer \| Lonkar, Pallavi \| Neubert, Hendrik \| Owens, Jane \| Binks, Michael \| Montolio, Marisol \| Phadke, Rahul \| Datson, Nicole \| Van Deutekom, Judith \| ... \| Arechavala-Gomeza, Virginia Journal of Neuromuscular Diseases, volume 6, issue 1, pages 147-159 (2019). 10.3233/JND-180357 Cited by (46) \| Cite \| Source
DMD TREATMENT: ANIMAL MODELS (journal article) Le Guiner, C. \| Moullier, P. \| McIntyre, M. \| Larcher, T. \| Adjali, O. \| LaFoux, A. \| Toumaniantz, G. \| Owens, J. \| Xiao, X. \| Binks, M. \| ... \| Samulski, R. Neuromuscular Disorders, volume 28 (2018). 10.1016/j.nmd.2018.06.248 Cite \| Source
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Domagrozumab (PF‐06252616), an Antimyostatin Monoclonal Antibody, in Healthy Subjects (journal article) Bhattacharya, Indranil \| Pawlak, Sylvester \| Marraffino, Shannon \| Christensen, Jared \| Sherlock, Sarah P. \| Alvey, Christine \| Morris, Carl \| Arkin, Steven \| Binks, Michael Clinical Pharmacology in Drug Development, volume 7, issue 5, pages 484-497 (2018). 10.1002/cpdd.386 Cited by (39) \| Cite \| Source
Safety, tolerability, efficacy and pharmacodynamics of the selective JAK1 inhibitor GSK2586184 in patients with systemic lupus erythematosus (journal article) Kahl, L \| Patel, J \| Layton, M \| Binks, M \| Hicks, K \| Leon, G \| Hachulla, E \| Machado, D \| Staumont-Sallé, D \| Dickson, M \| ... \| van Vollenhoven, R F Lupus, volume 25, issue 13, pages 1420-1430 (2016). 10.1177/0961203316640910 Cited by (49) \| Cite \| Source
Image analysis method to assess adhesion of Helicobacter pylori to gastric epithelium using confocal laser scanning microscopy (journal article) Reinhard, Joscha \| Basset, Christelle \| Holton, John \| Binks, Michael \| Youinou, Pierre \| Vaira, Dino Journal of Microbiological Methods, volume 39, issue 3, pages 179-187 (2000). 10.1016/S0167-7012(99)00118-9 Cited by (10) \| Cite \| Source
In vivo priming of T cells against cryptic determinants by dendritic cells exposed to interleukin 6 and native antigen (journal article) Drakesmith, Hal \| O’Neil, Deborah \| Schneider, Susanne C. \| Binks, Mike \| Medd, Patrick \| Sercarz, Eli \| Beverley, Peter \| Chain, Benjamin Proceedings of the National Academy of Sciences, volume 95, issue 25, pages 14903-14908 (1998). 10.1073/pnas.95.25.14903 Cited by (100) \| Cite \| Source \| Open Access
Intrinsic dendritic cell abnormalities in Wiskott-Aldrich syndrome (journal article) Binks, Michael \| Jones, Gareth E. \| Brickell, Paul M. \| Kinnon, Christine \| Katz, David R. \| Thrasher, Adrian J. European Journal of Immunology, volume 28, issue 10, pages 3259-3267 (1998). 10.1002/(SICI)1521-4141(199810)28:10<3259::AID-IMMU3259>3.0.CO;2-B Cited by (104) \| Cite \| Source \| Open Access
Intrinsic dendritic cell defects in Wiskott-Aldrich syndrome (journal article) Binks, M Molecular Immunology, volume 35, issue 11-12, pages 734- (1998). 10.1016/S0161-5890(98)90404-7 Cite \| Source
ANTIGEN PROCESSING AND PRESENTATION (book chapter) In Cellular Immunology Chain, B.M. \| Sealy, L \| Katz, D.R. \| Binks, M. Elsevier (1994) 10.1016/B978-0-12-208885-8.50015-6 Cited by (2) \| Cite \| Source